LV non compaction

Your credits are exhausted. You can purchase a top-up or subscribe to a plan to continue using Orris. If you're already subscribed, your daily credits will reset tomorrow.

LV non compaction

Reading File

Finding Sources

Searching Images

left ventricular noncompaction cardiomyopathy echocardiogram MRI trabeculations

Searching PubMed

"left ventricular noncompaction" cardiomyopathy

Searching the Web

left ventricular noncompaction cardiomyopathy diagnosis criteria management 2025

Reading File

Left Ventricular Noncompaction (LVNC)

Definition and Pathology

LVNC (also called left ventricular hypertrabeculation or "spongy myocardium") is a myocardial disorder characterized by a thin outer compacted layer of normal myocardium and a thickened inner noncompacted layer made of prominent trabeculae with deep intertrabecular recesses that communicate directly with the ventricular cavity - Goldman-Cecil Medicine, p. 863-867.

The old theory held that this resulted from arrested embryologic compaction of the trabecular meshwork during fetal development. Current evidence instead suggests the compact wall grows by intrinsic myocyte proliferation rather than compaction of pre-existing trabeculae, which is why many authors now prefer the term "excessive trabeculation" over "noncompaction" - Goldman-Cecil Medicine, p. 863.

Diagnostic Criteria

Diagnosis relies on imaging, most often echocardiography and cardiac MRI:

Echocardiography: A ratio of noncompacted-to-compacted myocardium at end-systole of ≥2:1, with hypokinesis/thickening typically localized to the apex, mid-lateral, and mid-inferior walls, plus color Doppler flow extending into the trabecular recesses - Textbook of Clinical Echocardiography, p. 4207.
Cardiac MRI (CMR): Generally more sensitive than echo; a noncompacted-to-compacted ratio >2.3 at end-diastole is a commonly cited CMR threshold (per StatPearls/Fuster and Hurst's).
CT can also depict excessive trabeculation with less definition but less time/expense.

Important caveat from the literature: current criteria are based on morphology alone, are inconsistent and poorly standardized across modalities, and have low specificity - excessive trabeculation is seen in normal, physiologic remodeling (see below), so diagnosis requires caution and clinical correlation, not imaging alone - Braunwald's Heart Disease, p. 1465-1472; Fuster and Hurst's The Heart, p. 1391-1406.

LVNC in Healthy Subjects (Physiologic Trabeculation)

Excessive trabeculation meeting "LVNC criteria" can be found in:

Athletes (especially endurance-trained, and more common in Black individuals)
Pregnant women (may appear de novo and regress after delivery)
Otherwise healthy people with no functional consequence

This overlap is why a growing body of opinion now frames LVNC less as a discrete disease and more as a phenotypic trait with a wide spectrum, from benign anatomic variant to a true cardiomyopathy - Fuster and Hurst's The Heart, p. 1397-1405; supported by a 2022 Revista Española de Cardiología review questioning whether LVNC is "a disease or a phenotypic trait."

Genetics and Associations

Roughly one-third of cases have an identifiable genetic variant, most commonly in cardiac sarcomeric genes: MYH7, MYBPC3, TTN - Goldman-Cecil Medicine, p. 867.
Other implicated genes: nuclear envelope proteins, Z-line components, muscular dystrophy/myopathy genes, and ion channel genes - Fuster and Hurst's The Heart, p. 4650-4666.
LVNC overlaps genetically and phenotypically with dilated, hypertrophic, and restrictive cardiomyopathies - the same MYH7 mutation can produce classic HCM in one family member and LVNC-predominant remodeling in another (documented pedigree example with father/son both heart-transplant recipients carrying the identical MYH7 p.(Gly716Arg) variant) - Fuster and Hurst's The Heart, p. 1429.
Syndromic LVNC: Barth syndrome, Anderson-Fabry disease, Danon disease, and various congenital heart diseases (including bicuspid aortic valve, though this association is debated) - Fuster and Hurst's The Heart, p. 1428-1429.

Clinical Manifestations

When trabeculation is extensive, systolic function can be impaired, leading to the classic triad:

Heart failure
Ventricular arrhythmias
Systemic thromboembolism (from stasis in deep trabecular recesses)

Management

There is no LVNC-specific therapy. Management mirrors that of dilated cardiomyopathy:

Heart failure: standard guideline-directed medical therapy; beta-blockers may reduce LV mass (mechanism unclear, needs prospective validation)
Arrhythmias: standard monitoring/treatment; ICD indications follow the same criteria as other DCM patients
Anticoagulation: not routine - thromboembolic risk is mainly relevant in dysfunctional hearts (LV dilation + reduced systolic function), not in normal-function trabeculation. The CHADS2 score can help guide anticoagulation decisions in patients with increased LV trabeculation
Barth syndrome-specific care: G-CSF in high-risk situations, prophylactic antibiotics, uncooked cornstarch dietary supplementation, avoidance of succinylcholine, multidisciplinary pediatric-to-adult care
Pregnancy: isolated de novo LVNC in pregnancy with normal LV function may need only monitoring; if it evolves into peripartum cardiomyopathy, management follows PPCM protocols including possible anticoagulation

(Fuster and Hurst's The Heart, p. 1433-1434)

Recent Evidence Note

A 2025 narrative review (PMC12565534, covering literature through April 2025) reinforces that sarcomeric variants link LVNC to dilated/hypertrophic cardiomyopathies, and that current imaging criteria "blur the boundary" between disease and normal variant - consistent with the textbook material above. No systematic review or meta-analysis in the last 2 years contradicts the management principles described here; there are still no dedicated LVNC-specific clinical practice guidelines.

What are the diagnostic criteria and imaging features of LV non-compaction?

Reading File

Finding Sources

Searching Images

left ventricular noncompaction cardiac MRI trabeculated myocardium apex

Reading File

Diagnostic Criteria and Imaging Features of LV Noncompaction

The core problem: no gold standard

A key point from the cardiology literature (Fuster and Hurst's The Heart, Ch. 45) is that LVNC diagnosis rests entirely on imaging morphology - there is no shared, standardized criterion set, no functional/electrical/biochemical criterion, and no formal clinical practice guideline. Multiple competing criteria exist across echocardiography, CMR, and CT, which is why prevalence estimates vary enormously depending on which modality and threshold is used.

1. Echocardiography (first-line)

The most widely used echocardiographic criteria are the Jenni criteria, refined later by Stöllberger et al.:

Two-layered myocardial structure: a thin, compacted epicardial layer and a thick, noncompacted endocardial layer of prominent trabeculae
Noncompacted-to-compacted (NC/C) ratio ≥ 2 measured at end-systole, typically in the parasternal short- or long-axis view
Distinguishing regional pattern: hypokinesis and myocardial thickening concentrated in the apex, mid-lateral, and mid-inferior walls
Color Doppler demonstrating blood flow extending from the ventricular cavity directly into the deep intertrabecular recesses (this helps exclude a false "spongy" appearance and confirms the recesses communicate with the LV cavity, distinguishing LVNC from apical thrombus or false tendons)
Quantitative refinements have also been proposed using the fractal dimension (FD) of the endocardial border to distinguish normal from abnormal trabecular complexity, since normal individuals (especially Black patients) can have physiologically increased trabeculation - Textbook of Clinical Echocardiography, p. 4207; Fuster and Hurst's The Heart, p. 4885.

2. Cardiac MRI (CMR)

CMR is generally considered more sensitive than echocardiography and is used to confirm the diagnosis when echo is equivocal, and to assess fibrosis/thrombus:

Uses steady-state free precession (SSFP) cine sequences to sharply delineate the compacted vs. noncompacted layers
Most cited criterion (Petersen et al. / adapted by others): NC/C ratio > 2.3 at end-diastole, measured in long-axis views
Superior at visualizing ventricular thrombus and, with late gadolinium enhancement, myocardial fibrosis (a substrate for arrhythmia)
Because CMR is more sensitive, it detects far more "LVNC" in normal populations - a systematic review/meta-analysis (Ross et al., Eur Heart J 2020) found pooled adult prevalence of 14.79% by CMR vs. 1.28% by echocardiography, a roughly 12-fold difference - Fuster and Hurst's The Heart, p. 4865 (Fig. 45-4).

3. Multidetector CT (MDCT)

Can adequately depict increased trabeculation with shorter acquisition time and lower cost than CMR, but with less tissue definition/contrast resolution
Proposed diagnostic criteria exist (e.g., Melki et al.) but are used less often in routine practice, mainly when CMR is contraindicated

(The textbook's Figure 45 illustrates the same LVNC heart imaged side-by-side by 2D-TTE, CMR, and MDCT to show how the noncompacted trabecular layer and recesses appear across modalities.)

Supporting workup (beyond imaging)

Physical examination: usually nonspecific for isolated LVNC; extracardiac dysmorphic features may point toward a syndromic cause (Fabry, Danon, Barth syndrome, muscular dystrophies)
ECG: findings are nonspecific - can show conduction abnormalities, LVH-pattern changes, repolarization abnormalities, or preexcitation; not diagnostic alone
Genetics/family screening: recommended in probands with LVNC plus cardiomyopathy, LVNC with familial congenital heart disease, or syndromic features - but genetic testing has not been shown useful in adults with isolated LVNC and no family history, since no gene is specifically causal for the noncompaction morphology itself (variants found are the same ones causing DCM/HCM/RCM broadly - MYH7, MYBPC3, TTN, etc.)
Pathology/biopsy: rarely needed; when done, shows nonspecific interstitial fibrosis and endocardial thickening; occasionally reveals an alternative diagnosis such as cardiac amyloidosis mimicking apical hypertrabeculation

Why criteria matter clinically: the false-positive problem

Because all current criteria are purely morphologic, excessive trabeculation meeting "LVNC criteria" is common in normal hearts - notably in athletes, pregnant women, and Black individuals (a normal variant in this population), none of whom typically have functional impairment. Textbooks explicitly warn that isolated hypertrabeculation with normal LV size, systolic function, and wall thickness should not automatically be labeled a cardiomyopathy - correlate imaging with function, family history, and clinical context before diagnosing "LVNC cardiomyopathy" - Fuster and Hurst's The Heart, p. 4864-4885, 5144-5153.

Summary table

Modality	Key criterion	Notes
Echocardiography (Jenni/Stöllberger)	NC/C ratio ≥ 2 at end-systole + color Doppler flow into recesses	First-line, least sensitive, most specific
CMR	NC/C ratio > 2.3 at end-diastole	Most sensitive; best for thrombus/fibrosis; confirms equivocal echo
MDCT	Increased trabeculation on multiplanar reconstruction	Faster/cheaper alternative when CMR contraindicated; less used

If you want, I can go deeper into any single piece - for example the specific gene panels used in genetic testing, or how LVNC is distinguished from other causes of apical hypertrabeculation (e.g., apical HCM, cardiac amyloid, apical thrombus).

This is a shared conversation. Sign in to Orris to start your own chat.